Real Time Touch



new TOP 200 Companies filing patents this week

new Companies with the Most Patent Filings (2010+)




Real Time Touch

Lipocine Inc patents


Recent patent applications related to Lipocine Inc. Lipocine Inc is listed as an Agent/Assignee. Note: Lipocine Inc may have other listings under different names/spellings. We're not affiliated with Lipocine Inc, we're just tracking patents.

ARCHIVE: New 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 | Company Directory "L" | Lipocine Inc-related inventors


Pharmaceutical compositions and dosage forms for administration of hydrophobic drugs

Pharmaceutical compositions and dosage forms for administration of hydrophobic drugs are provided. The pharmaceutical compositions include a therapeutically effective amount of a hydrophobic drug, preferably a steroid; a solubilizer, and a surfactant. ... Lipocine Inc

High-strength testosterone undecanoate compositions

The present disclosure is drawn to pharmaceutical compositions and oral dosage capsules containing testosterone undecanoate, as well as related methods. The capsule includes a capsule shell and a capsule fill. ... Lipocine Inc

High-strength testosterone undecanoate compositions

The present disclosure is drawn to pharmaceutical compositions and oral dosage capsules containing testosterone undecanoate, as well as related methods. The capsule includes a capsule shell and a capsule fill. ... Lipocine Inc

Composition and method for oral delivery of androgen prodrugs

Provided oral testosterone undecanoate compositions can be administered to hypogonadal males with a meal without the fat content of the meal substantially effecting bioavailability.. . ... Lipocine Inc

Oral testosterone tridecanoate therapy

The present disclosure provides methods and compositions for testosterone replacement therapy. The methods and compositions employ a fixed dose dosing regimen that does not require titration or dose adjustments and that can provide a therapeutically effective amount of a testosterone ester while avoiding unacceptably high testosterone levels.. ... Lipocine Inc

High-strength testosterone undecanoate compositions

The present disclosure is drawn to pharmaceutical compositions and oral dosage capsules containing testosterone undecanoate, as well as related methods. The capsule includes a capsule shell and a capsule fill. ... Lipocine Inc

Oral testosterone undecanoate therapy

The present disclosure provides methods and compositions for testosterone replacement therapy. The methods and compositions employ a fixed dose dosing regimen that does not require titration or dose adjustments and that can provide a therapeutically effective amount of a testosterone ester while avoiding unacceptably high testosterone levels.. ... Lipocine Inc

Pharmaceutical compositions and dosage forms for administration of hydrophobic drugs

Pharmaceutical compositions and dosage forms for administration of hydrophobic drugs, particularly steroids, are provided. The pharmaceutical compositions include a therapeutically effective amount of a hydrophobic drug, preferably a steroid; a solubilizer, preferably a vitamin e substance; and a surfactant. ... Lipocine Inc

Solid carriers for improved delivery of active ingredients in pharmaceutical compositions

The present invention provides solid pharmaceutical compositions for improved delivery of a wide variety of pharmaceutical active ingredients contained therein or separately administered. In one embodiment, the solid pharmaceutical composition includes a solid carrier, the solid carrier including a substrate and an encapsulation cost on the substrate. ... Lipocine Inc

Bioavailable solid state (17- β)-hydroxy-4-androsten-3-one esters

Disclosed are bioavailable solid state (17-β)-hydroxy-4-androsten-3-one esters suitable for pharmaceutical uses and administration to mammals in need of (17-β)-hydroxy-4-androsten-3-one.. . ... Lipocine Inc

High-strength testosterone undecanoate compositions

The present disclosure is drawn to pharmaceutical compositions and oral dosage capsules containing testosterone undecanoate, as well as related methods. The capsule includes a capsule shell and a capsule fill. ... Lipocine Inc

Testosterone undecanoate compositions

The present disclosure is drawn to pharmaceutical compositions and oral dosage forms containing testosterone undecanoate, as well as related methods of treatment. In one embodiment, the oral dosage form can include a therapeutically effective amount of testosterone undecanoate and a pharmaceutically acceptable carrier. ... Lipocine Inc

(17-ß)-3-oxoandrost-4-en-17-yl undecanoate compositions and methods of their preparation and use

Disclosed herein are compositions having a lipophilic active agent and methods of their use.. . ... Lipocine Inc

Pharmaceutical compositions with synchronized solubilizer release

Pharmaceutical compositions with synchronized solubilizer release as well as various methods associated therewith, are disclosed and described. More specifically, the aqueous solubility of a drug is enhanced by synchronized release of a solubilizer.. ... Lipocine Inc

03/22/18 / #20180078568

Pharmaceutical composition and methods

Disclosed herein are compositions having a lipophilic active agent and methods of their use.. . ... Lipocine Inc

03/15/18 / #20180071312

High-strength testosterone undecanoate compositions

The present disclosure is drawn to pharmaceutical compositions and oral dosage capsules containing testosterone undecanoate, as well as related methods. The capsule includes a capsule shell and a capsule fill. ... Lipocine Inc

03/01/18 / #20180055854

High-strength testosterone undecanoate compositions

The present disclosure is drawn to pharmaceutical compositions and oral dosage capsules containing testosterone undecanoate, as well as related methods. The capsule includes a capsule shell and a capsule fill. ... Lipocine Inc

12/14/17 / #20170354663

Steroidal compositions

Provided herein are steroid containing compositions suitable for providing therapeutically effective amounts of at least one steroid to individuals. Also provided herein are compositions comprising testosterone and/or testosterone derivatives suitable for providing therapeutically effective and safe amounts of testosterone over periods of time. ... Lipocine Inc

11/09/17 / #20170319596

Methods for improving quality of life or sexual domain function and composition useful in the methods

This application relates to methods and compositions useful for improving quality of life, sexual domain function or a combination thereof.. . ... Lipocine Inc

09/07/17 / #20170252357

Steroidal compositions

Provided herein are steroid containing compositions suitable for providing therapeutically effective amounts of at least one steroid to individuals. Also provided herein are compositions comprising testosterone and/or testosterone derivatives suitable for providing therapeutically effective and safe amounts of testosterone over periods of time. ... Lipocine Inc

08/31/17 / #20170246187

(17-ß)-3-oxoandrost-4-en-17-yl tridecanoate compositions and methods of their preparation and use

Described here are substantially pure (17-β)-3-oxoandrost-4-en-17-yl tridecanoate compositions, methods of their preparation and uses thereof.. . ... Lipocine Inc

08/31/17 / #20170246186

High-strength testosterone undecanoate compositions

The present disclosure is drawn to pharmaceutical compositions and oral dosage capsules containing testosterone undecanoate, as well as related methods. The capsule includes a capsule shell and a capsule fill. ... Lipocine Inc

08/03/17 / #20170216312

Sterodial compositions

Provided herein are steroid containing compositions suitable for providing therapeutically effective amounts of at least one steroid to individuals. Also provided herein are compositions comprising testosterone and/or testosterone derivatives suitable for providing therapeutically effective and safe amounts of testosterone over periods of time. ... Lipocine Inc

08/03/17 / #20170216311

High-strength testosterone undecanoate compositions

The present disclosure is drawn to pharmaceutical compositions and oral dosage capsules containing testosterone undecanoate, as well as related methods. The capsule includes a capsule shell and a capsule fill. ... Lipocine Inc

03/02/17 / #20170056415

Bioavailable solid state (17-β)-hydroxy-4-androsten-3-one esters

Disclosed are bioavailable solid state (17-β)-hydroxy-4-androsten-3-one esters suitable for pharmaceutical uses and administration to mammals in need of (17-β)-hydroxy-4-androsten-3-one.. . ... Lipocine Inc

02/09/17 / #20170035781

17-hydroxyprogesterone ester-containing oral compositions and related methods

The present invention provides for bioavailable oral dosage forms containing esters of 17-hydroxyprogesterone as well as related methods. The oral dosage forms can be formulated for pregnancy support and can include a therapeutically effective amount of an ester of 17-hydroxyprogesterone and a pharmaceutically acceptable carrier. ... Lipocine Inc

01/26/17 / #20170020893

Lipobalanced long chain testosterone prodrugs for oral delivery

The present disclosure is drawn to oral pharmaceutical compositions and dosage forms containing select lipobalanced testosterone prodrugs and related methods. In one embodiment of the present invention, an oral pharmaceutical composition for administration to subjects in need of testosterone is provided. ... Lipocine Inc

01/12/17 / #20170007623

17-hydroxyprogesterone ester-containing oral compositions and related methods

The present invention provides for bioavailable oral dosage forms containing esters of 17-hydroxyprogesterone as well as related methods. The oral dosage forms can be formulated for pregnancy support and can include a therapeutically effective amount of an ester of 17-hydroxyprogesterone and a pharmaceutically acceptable carrier. ... Lipocine Inc

01/12/17 / #20170007622

High-strength testosterone undecanoate compositions

The present disclosure is drawn to pharmaceutical compositions and oral dosage capsules containing testosterone undecanoate, as well as related methods. The capsule includes a capsule shell and a capsule fill. ... Lipocine Inc








ARCHIVE: New 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009



###

This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. Freshpatents.com is not affiliated or associated with Lipocine Inc in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Lipocine Inc with additional patents listed. Browse our Agent directory for other possible listings. Page by FreshPatents.com

###